BiotechTube

Clascoterone Cream 1%

Phase 2Recruiting
0 views this week 0 watching⚡ Active
Interest: 42/100
42
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Papular-pustular Rosacea

Conditions

Papular-pustular Rosacea, Papulopustular Rosacea (PPR), Papulopustular Rosacea

Trial Timeline

Mar 14, 2025 → Sep 30, 2025

NCT ID
NCT06952517

About Clascoterone Cream 1%

Clascoterone Cream 1% is a phase 2 stage product being developed by Sun Pharmaceutical for Papular-pustular Rosacea. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06952517. Target conditions include Papular-pustular Rosacea, Papulopustular Rosacea (PPR), Papulopustular Rosacea.

Hype Score Breakdown

Clinical
12
Activity
15
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT06952517Phase 2Recruiting